Systemic and Peritoneal Inflammatory Response In Robotic-assisted And Laparoscopic Surgery for Colon Cancer

NCT ID: NCT04687384

Last Updated: 2021-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current hypothesis is that robotic-assisted surgery results in a reduced systemic and peritoneal inflammatory response (SIRS) compared to laparoscopic surgery in the treatment of colon cancer. The purpose is to evaluate differences in the peritoneal and systemic inflammatory response in robot-assisted and laparoscopic surgery of patients undergoing resection for colon cancer in a randomized, blinded controlled trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonic Neoplasms Colon Cancer Systemic Inflammatory Response Syndrome Inflammation Robotic Surgical Procedures Laparoscopy Peritoneal Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic-assisted surgery

Patients undergoing robotic-assisted colectomy for colonic neoplasm

Group Type EXPERIMENTAL

Robotic-assisted colectomy

Intervention Type PROCEDURE

Robotic-assisted colectomy performed by usage of da Vinci Xi robotic technology

Laparoscopy

Patients undergoing conventional laparoscopic colectomy for colonic neoplasm

Group Type ACTIVE_COMPARATOR

Conventional laparoscopic colectomy

Intervention Type PROCEDURE

Conventional laparoscopic colectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robotic-assisted colectomy

Robotic-assisted colectomy performed by usage of da Vinci Xi robotic technology

Intervention Type PROCEDURE

Conventional laparoscopic colectomy

Conventional laparoscopic colectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective robotic-assisted or laparoscopic surgery for right-sided, left-sided and sigmoid colon cancer
* Aged ≥ 18
* ASA-score ≤ 3
* Tumor-stage (Tx-T4a)
* Endoscopic suspected colon cancer
* Histological verified adenocarcinoma, signet ring cell carcinoma, undifferentiated cancer, medullary carcinoma, or another malignant tumor type originating from colon
* Patients must give informed written consent
* Patients must be able to understand Danish language

Exclusion Criteria

* Carcinoma of the transverse colon or synchronous colorectal cancer
* Previous history of colon cancer
* Previous open major abdominal surgery with exception of open appendectomy and cholecystectomy.
* Metastatic disease
* Pregnancy
* History of psychiatric or addictive disorder that would prevent the patient from participating in the trial
* Emergency colon surgery
* Co-existing inflammatory bowel disease
* Co-existing immunological disease that requiring ingestion of systemic immunomodulatory drugs (DMARD - disease modifying anti-rheumatic drugs), corticosteroids and biologic disease-modifying anti-rheumatic drugs.
* Daily consumption of NSAID drugs
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region of Southern Denmark

OTHER

Sponsor Role collaborator

University of Southern Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pedja Cuk, MD

Role: PRINCIPAL_INVESTIGATOR

Surgical Department, Hospital of Southern Jutland, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of Southern Denmark

Aabenraa, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pedja Cuk, MD

Role: CONTACT

+4579970000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pedja Cuk, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Cuk P, Tiskus M, Moller S, Lambertsen KL, Backer Mogensen C, Festersen Nielsen M, Helligso P, Gogenur I, Bremholm Ellebaek M. Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial. Br J Surg. 2024 Mar 2;111(3):znae049. doi: 10.1093/bjs/znae049.

Reference Type DERIVED
PMID: 38445434 (View on PubMed)

Cuk P, Pedersen AK, Lambertsen KL, Mogensen CB, Nielsen MF, Helligso P, Gogenur I, Ellebaek MB. Systemic inflammatory response in robot-assisted and laparoscopic surgery for colon cancer (SIRIRALS): study protocol of a randomized controlled trial. BMC Surg. 2021 Oct 11;21(1):363. doi: 10.1186/s12893-021-01355-4.

Reference Type DERIVED
PMID: 34635066 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

75709

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.